NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Fresenius’

26 February 2014

Bridgepoint’s Diaverum exit hopes rise amid interest from trade giant Fresenius

Thrasos Therapeutics kidney - AltAssets Private Equity News The world’s biggest provider of dialysis treatment has admitted it could be interested in Bridgepoint-backed rival Diaverum as the buyout house looks for an exit.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014